Skip to content

A trial of Plasmalyte vs Bicarbonate based prime in patients undergoing cardiopulmonary bypass

Quantification of the role of acetate and gluconate to the changes in anion gap and strong ion gap caused by Plasmalyte 148 cardiopulmonary bypass pump prime: A comparison with bicarbonate

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000267055
Enrollment
30
Registered
2010-03-31
Start date
2009-01-20
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Heart operations is frequently accompanied by a degree of inflammation and irregular heart beat.This study aims to determine if the use of a solution containing bicarbonate during heart operations will reduce the amount of inflammation and improve heart rhythm. During heart bypass surgery, patients' circulation is supported by a heart lung machine. During this process, the patient's blood is mixed with around 2 L of fluid. In Brisbane, we have developed a fluid for use during heart surgery. Initial results suggest that it maintains the acid levels in the blood better than the conventionally used fluid. This project is seeking to determine whether the new fluid also improves the overall well being of the patient. If shown to improve the overall well being of the patient, it has the potential to reduce hospital stay and hospital costs.

Interventions

Patients undergoing cardiopulmonarybypass will receive a pump prime of 2 litres of bicarbonate based prime . The bicarbonate based prime has the following composition.(Sodium (Na) 140 mmol/L, Chloride (Cl) 116 mmol/L and bicarbonate 24 mmol/L). The pump flow rates and the membrane oxygenator protocls will be as per standard practice.

Sponsors

Princess Alexandra hospital
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Patients undergoing elective or urgent coronary artery bypass grafting

Exclusion criteria

Re-do cardiac surgery Emergent surgery Renal failure Inability to provide informed consent

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 29, 2026